Skip to main content
. Author manuscript; available in PMC: 2015 Jun 3.
Published in final edited form as: Urology. 2012 Oct 26;80(6):1319–1325. doi: 10.1016/j.urology.2012.06.080

Figure 2.

Figure 2

Kaplan-Meier plot of clinical progression-free survival probabilities for patients categorized as at reduced risk for clinical recurrence and not at reduced risk for recurrence based on ProsVue results in relation to groups of men with pathologic Gleason score <7 and ≥7 prostate cancers.